Results 181 to 190 of about 936,926 (207)

Bacterial conjunctivitis and keratitis

Current Opinion in Ophthalmology, 1990
O. P. van Bijsterveld, O. L.H. van Hemel
openaire   +1 more source

Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis

Current Medical Research and Opinion, 2009
Wolfgang Haas, Timothy W Morris, Michael R Paterno   +2 more
exaly  

[Bacterial conjunctivitis].

Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 1987
K W, Ruprecht, A A, Bialasiewicz
openaire   +1 more source

Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis

Expert Opinion on Pharmacotherapy, 2009
Joseph S Bertino Jr, Jin-Zhong Zhang
exaly  

Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops

Canadian Journal of Ophthalmology, 2002
W Bruce Jackson
exaly  

Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study

Clinical Therapeutics, 2009
Michael R Paterno, Timothy L Comstock, Dale W Usner   +2 more
exaly  

[Bacterial conjunctivitis].

Ryoikibetsu shokogun shirizu, 1999
M, Ooishi, M, Miyao
openaire   +1 more source

BACTERIAL CONJUNCTIVITIS 372.05 (Infective Conjunctivitis, Mucopurulent Conjunctivitis, Purulent Conjunctivitis)

2008
Aziz Sheikh, Brian Hurwitz
openaire   +1 more source

A randomized, investigator-masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment of acute bacterial conjunctivitis

Current Medical Research and Opinion, 2005
Scott M Whitcup
exaly  

Treatment of Bacterial Conjunctivitis in Children

Pediatric Annals, 2011
openaire   +2 more sources